Comments 
Print 
Mail 
Large Medium SmallGui Zhen Tang, a Chinese pharmaceutical company known for its medicine made with bear bile, suspended the examination process for its initial public offering on Monday, the China Securities Regulatory Commission said.
The company, founded in 2000 and based in Fujian province, has been targeted by animal welfare activists for its alleged cruel treatment of bears.
Public outcry against the company's IPO application emerged in February 2012, when it appeared on a CSRC list of firms awaiting approval by the Growth Enterprise Board to trade on the Shenzhen Stock Exchange.
Animal rights activists believe that the public outcry is the reason behind the suspension of the IPO application.
The company has not openly talked about the issue.
Under CSRC rules, the suspension of the examination, however, does not equal a termination of the IPO, according to the State broadcaster China Central Television.
Watermelons now come with scannable data
Rubber Duck falls into Victoria Harbor
Car wreck over car parts quality claim
Gales, hailstorms batter villages in SW China
Ram with artificial heart sets survival record
The future of wearable computers
Anniversary quake drill jolts students
15,000 tour memorial hall on quake anniversaryCopyright 1995 - 2010 . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
